AZD1386   Click here for help

GtoPdb Ligand ID: 7820

Synonyms: AZ12457709 | AZD 1386 | AZD-1386 | KB-270807
Compound class: Synthetic organic
Comment: AZD1386 is an orally available antagonist of the transient receptor potential channel TRPV1. It acts as a competitive antagonist at the channel's capsaicin binding site .
This compound was in the AstraZeneca/MRC repurposing list from 2011
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 3
Topological polar surface area 78.51
Molecular weight 423.06
XLogP 3.71
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C1NC(=O)C2(N1)c1cc(Cl)cc(c1N(C2=O)Cc1cccc(c1)C(F)(F)F)C
Isomeric SMILES O=C1NC(=O)C2(N1)c1cc(Cl)cc(c1N(C2=O)Cc1cccc(c1)C(F)(F)F)C
InChI InChI=1S/C19H13ClF3N3O3/c1-9-5-12(20)7-13-14(9)26(16(28)18(13)15(27)24-17(29)25-18)8-10-3-2-4-11(6-10)19(21,22)23/h2-7H,8H2,1H3,(H2,24,25,27,29)
InChI Key DXDVSYALLVVBOV-UHFFFAOYSA-N
References
1. MRC. 
AZD1386 TRPV1 ion channel inhibitor.
Accessed on 28/10/2014. Modified on 28/10/2014. MRC/AstraZeneca: Mechanisms of Disease Call, http://webarchive.nationalarchives.gov.uk/20120104105854/http://www.mrc.ac.uk/consumption/groups/public/documents/content/mrc008366.pdf
2. Quiding H, Jonzon B, Svensson O, Webster L, Reimfelt A, Karin A, Karlsten R, Segerdahl M. (2013)
TRPV1 antagonistic analgesic effect: a randomized study of AZD1386 in pain after third molar extraction.
Pain, 154 (6): 808-12. [PMID:23541425]